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Waiting times in the UK for an autism diagnostic assessment have increased rapidly in the last five 
years. This review explored research (including ‘grey’ literature) to uncover the current evidence base 
about autism diagnostic pathways and what works best, for whom and in what circumstances, to 
deliver high quality and timely diagnosis.  
 
Design  
We performed a Rapid Realist Review (RRR) consistent with recognised standards for realist syntheses. 
We collected 129 grey literature and policy/guidelines and 220 articles from seven databases (Jan 
2011-Dec 2019). We developed programme theories of how, why and in what contexts an intervention 
worked, based on cross-comparison and synthesis of evidence. The focus was on identifying factors 
that contributed to a clearly defined intervention (the diagnostic pathway), associated with specific 
outcomes (high quality and timely), within specific parameters (Autism diagnostic services in 
Paediatric and Child & Adolescent Mental Health services in the UK). Our Expert Stakeholder Group, 
including representatives from local parent forums, national advocacy groups and clinicians, was 
integral to the process. 
 
Results  
Based on 45 relevant articles, we identified seven programme theories that were integral to the 
process of diagnostic service delivery. Four were related to the clinical pathway: initial recognition of 
possible autism; referral and triaging; diagnostic model; and providing feedback to parents. Three 
programme theories were pertinent to all stages of the referral and diagnostic process: working in 
partnership with families; inter-agency working; and training, service evaluation and development.  
 
Conclusions  
This theory informed review of childhood autism diagnostic pathways identified important aspects 
that may contribute to efficient, high quality and family-friendly service delivery. The programme 
theories will be further tested through a national survey of current practice and in-depth longitudinal 
case studies of exemplar services.   
 
Trial registration number NCT04422483.  
 




 This realist review focussed on reviewing and synthesising recent evidence to determine what 
approaches to autism diagnostic assessment worked best, for whom and in what context. The 
approach is better suited than more empirical methods that assume there is one model to suit 
all situations. 
 Our Expert Stakeholder Group and parent representatives engaged with all stages of the 
review and enabled an iterative approach to identifying relevant literature and refining our 
findings. 
 As appropriate to our research question, we limited the search to UK literature but may have 
missed relevant literature from similar health systems. Although synthesis was based on UK 
literature, we have considered how this relates to relevant international literature. 
Introduction   
The number of children and young people (CYP) diagnosed with autism spectrum disorder (autism) 
has increased significantly in recent years (1-3) with a median age for diagnosis of 55 months (4). This 
international phenomena is reflected in increasing pressures on diagnostic assessment and long 
waiting times in some services (5), with associated family dissatisfaction (6). The UK National Health 
Service (NHS) Long Term Plan (7) highlighted the need for research to identify the most effective ways 
to improve timely access to diagnosis whilst maintaining high-quality assessment for this service user 
group.  
Autism is characterised by persistent severe deficits in social interaction, social communication, and 
restricted, repetitive, inflexible patterns of behaviour and interests (8), although the level of 
symptoms varies considerably between individuals. It is commonly associated with other 
neurodevelopmental and mental health conditions, such as anxiety, ADHD and developmental 
language disorder (9-11), making reliable diagnosis a complex process. National guidelines for Autism 
in the UK (12) recommend multidisciplinary assessment, with the skills to consider both the presence 
of other neurodevelopmental and mental health conditions (for example, ADHD, anxiety disorders), 
and co-existing conditions (for example eating or sleeping related). However, this holistic assessment 
is time-consuming and costly (13, 14). There are significant variations between diagnostic pathways, 
which some have defined as ‘complex interventions for mutual decision making, organisation and 
standardization of predictable care for a well-defined group of patients during a well-defined period’ 
(15), and only limited evidence of which pathways work best, for whom and in what circumstances. 
Although the formal research base is limited, some local providers have already reconfigured their 
services to address these issues (16-18). However, robust evidence is needed to identify which care 




assessment in a timely, clinically valid, and family-friendly way. This Rapid Realist Review (RRR), the 
first step in a national Realist Evaluation of Autism ServiCe Delivery (RE-ASCeD), aimed to explore how 
particular approaches aspired to deliver high quality and timely autism diagnostic services (19). High 
quality was defined as compliant with NICE guidelines (12). ‘Timely’ refers to diagnostic pathways that 
must be started within three months of referral, in-line with NICE guidelines (1), and last no more than 
one calendar year.  
This study aimed to explore research evidence about autism diagnostic pathways to determine what 
works best, for whom and in what circumstances. The RRR aimed to use the literature to address the 
following questions: 
1. How do various pathways of autism diagnostic and support services address the differing 
needs of service users and what contexts and mechanisms affect their ability to do so? 
2. How do different pathways of autism diagnostic and support services improve service user 
diagnostic experience? 
3. What aspects of implementation, staffing and organisational context influence how care 
pathways for autism diagnostic and support services operate? 
 
Method 
Autism diagnostic care pathways vary in terms of complex differences in local service configurations 
and settings, lending itself to realist review that can tease out contextual factors, resources and 
responses of those delivering and accessing the services. A systematic review may not be best 
matched to the heterogeneity of autism diagnostic services nor to capturing what is most helpful for 
policy decisions. Our focus was exploring solutions, so we did not focus on wider constraints, already 
widely documented, and incorporating chronic underfunding; increasing caseloads; reduced training 
budgets; and recruitment/retention issues, particularly paediatricians, child psychiatrists, clinical 
psychologists and SALTS (20, 21). Similarly, we did not focus on causes of service user dissatisfaction, 
rather ways of addressing it.  
A RRR is a well-established approach to synthesising evidence within a compressed time period and 
the key steps are consistent with the RAMESES standards for realist syntheses (22); thus the difference 
is the timeframe, not the level of rigour. Additionally, RRR is explicitly designed to engage with 
stakeholders to accelerate the search process and validate findings (17). Our Expert Stakeholder 
Group included clinicians (consultant paediatricians, child psychology, speech and language therapy 




who were involved in all stages of the process (19). Ethical approval was not required because 
stakeholders were acting as research advisers, not participants (23). 
Realist reviews do not seek to compare interventions, rather they present evidence as programme 
theories (PTs) which are key features of the service and describe what appears to lead to certain 
outcomes (24), often phrased as ‘if…. Then…’ statements. PTs are supported by details of the context 
(C), mechanisms (M) and outcomes (O). These relationships are presented as CMO configurations (25). 
A realist approach requires starting with an initial PT of what should work and what outcomes are 
expected from a complex intervention; our PT was based on NICE 2011 guidance (12), the project 
team and Expert Stakeholder Group: 
If there is a MDT assessment by a team with competencies in child neurodevelopment and mental 
health (context), then Autism will be recognised as a complex condition that relies on detailed 
history and observation across settings (mechanism) to diagnose it. This will lead to accurate 
diagnosis, recognition of associated co-occurring conditions such as ADHD and intellectual 
disability (outcome), and the ruling out of complex differential diagnoses. This will also create, 
whilst not an explicit part of this project, an accurate picture of a child’s strengths and needs to 
inform individualised packages of support and intervention through health, education and social 
care (outcome). 
We worked backwards from the intended outcomes although we know in practice that complex 
interventions operating in different health and social care environments do not lead to the same 
outcomes across services because of differing contexts (for example, differences between services, 
ways of operationalizing and differences in recipient populations). Therefore, what is required is an 
understanding of what needs to be in place (circumstances or context), to trigger mechanisms (that 
can be responses or resources) that lead to the desired (intended) outcomes or other unintended 
outcomes.  
Changes to protocol 
No changes to the review process proposed in the published protocol 
(https://bmjopen.bmj.com/content/10/7/e037846).  
Search methods 
This RRR was carried out from 1 September 2019 to 30 June 2020 following RAMESES standards (24) 
for realist reviews. Through discussions within the RE-ASCeD project team and with our expert 
stakeholders, we confirmed and refined the research questions and scope; prioritised areas for 
investigation; identified search terms; and collected grey literature, policy and guideline papers 




Search terms were identified and developed with support from the RE-ASCeD project team and expert 
stakeholders. The primary search was conducted across Medline (Ovid), Embase (Ovid), PsycINFO 
(Ovid), Social Policy & Practice (Ovid), CINAHL Plus (EBSCO), Cochrane Library and Web of Science 
(Clarivate) limited by date (2011–2019), language (English) and country (UK only). Our focus was a 
clearly defined intervention (the diagnostic pathway, from receipt of referral to diagnosis), associated 
with specific outcomes (high quality and timely) within a particular set of parameters (autism/CAMHS 
services in the UK). All study types were included. The search strategy was created by an information 
specialist (AP) using a combination of free text and MeSH index terms after iterative pilots in Medline 
and adapted for each database. Search strings were based on a combination of terms covering 
“Children”, AND “Autism” AND how they “Relate to diagnostic pathway OR assessment”. For full 
search terms see Supplementary Document 1. Table 1 provides our inclusion/exclusion criteria.  
Secondary searching was conducted iteratively throughout the review with input from our expert 
stakeholders. Two reviewers used papers identified in the primary and background search to look 
through reference lists for relevant articles; check forward citations; and search key authors and 
research teams to identify further literature, using Google scholar. Primary and background searches 
were restricted to UK only, given UK NHS context. On the advice of our expert stakeholders, we then 
reviewed high level national policy documents and guidelines and a few research articles from similar 
countries (USA, Canada, Australia, New Zealand) to help elucidate findings. 
Table 1 Inclusion/exclusion criteria  
Inclusion criteria: 
 Children (preschool, primary or secondary school and adolescents) with Autism Spectrum 
Disorder or Autism spectrum condition 
 UK healthcare system (England, Scotland, Wales and N. Ireland) 
 Published 2011 onwards when the NICE guidelines for recognition, referral and diagnosis 
of autism in under 19s (2011) was published 
 Relates to diagnostic pathway and model of service provision or relates to assessment 
process e.g. single discipline (paediatric consultant) or multidisciplinary  
Primary exclusion criteria: 
 Non-UK based literature 
 Relates only to adult diagnostic pathway 
 Relates only to tertiary services 
 Only relates to treatment  
 Relates to support services only after diagnosis. 
Secondary exclusion criteria:  
 Descriptive or irrelevant commentary on materials we already included; no added insights 
relevant to context or mechanisms   
 Specific tools in terms of assessment tools or psychometric properties e.g. 
reliability/validity of the tool 




 Studies only related to symptoms or aetiology 
 Articles about special needs in general, no mention of ASD (or ADHD) 
 Duplicate material of Co-Is’ previous research, excluded by Co-Is  
 Conference paper with only abstract available 
 The data collected or published on-line before 2011 
 
Article selection and appraisal  
As shown in Figure 1, we collected 294 articles from the primary search , 129 grey literature records 
suggested by the RE-ASCeD project team members and our expert stakeholders, with overall 338 
items once duplicates removed. Furthermore, 9 papers were collected via iterative secondary 
searches by searching all publications for key authors using Google Scholar and consulting our Expert 
Stakeholder Group. Two researchers (VA and WZ) carried out screening in two stages: an initial stage 
by title and abstract and second stage by full-text. Title-sifting of papers that deemed ‘relevant’ or 
‘maybe relevant’ from both stages was also cross-checked by three team members (PW, WF and IM). 
Data extraction and appraisal were carried out by two researchers (VA and WZ) using a hybrid 
approach (26, 27): basic details from each included article (n=79) were recorded; appraisal of evidence 
was based on concepts of relevance, rigour and richness (26, 27), with highly relevant articles (n=45, 
including nine from iterative secondary search) coded in NVivo.  For 20% of papers, a series of 
calibration exercises were undertaken by the RRR Lead (PW). When two reviewers were uncertain 
about the extraction or appraisal of a paper, this was discussed with the RRR Lead (PW). The quality 
and relevance of the selected papers were also assessed during the synthesis process by members 
from the RE-ASCeD project team. 
Mapping the sources to test and develop PTs, we divided papers involved in NVivo analysis into three 
categories: 1) key papers that described a model of service delivery (e.g. integrated neuro-
developmental service) in detail and were conceptually rich, 2) ‘medium’ papers that mentioned a 
model with some useful information but were not conceptually rich, 3) papers with a few ‘nuggets’ 
(28) relevant to PTs. This helped us focus on key and medium papers (Supplementary Document 2) 
that could contribute most to developing a conceptual framework (29) and refining PTs.  
Synthesis and refinement  
Based on analysis of individual papers, we then conducted cross-evidence comparisons to build PTs 
and confirm/refute and refine CMO configurations; both synthesis and refining the evidence  involved 
substantial discussion of ‘contradictory’ evidence, or unintended outcomes. We also consulted with 
our expert stakeholders iteratively during the review process and at a data interpretation workshop 
in April 2020. Our expert stakeholders collectively reviewed the PTs, provided feedback and were 
invited to identify any omissions based on their clinical experience. We also asked them to suggest 




workshop, two reviewers (VA and WZ) checked and added new papers suggested by our expert 
stakeholders; refined the programme theories and conceptual framework. 
Insert: Figure 1. Search and review flow diagram.  
 
Patient and public involvement 
Our co-investigators included a patient and public involvement (PPI) representative from a local 
parent organisation (West Sussex Parent Carer Forum) who was able to consult a wider group of 
families with lived experience and a parent who had previously managed Sussex Autism Support. Our 
PPI representatives were equal partners within the Expert Stakeholder Group. This helped focus the 
review on the questions they were most interested in answering and enabled the identification of 
salient grey or unpublished documents for review (30).  PPI was embedded into the review protocol 
and was particularly helpful when synthesising and interpreting the data. A separate PPI Reference 
Group (all parents of CYP with autism), whose inception was delayed due to covid-19, is integral to 
the wider project.  
Results  
We developed seven PTs, based on cross-comparison and synthesis of 45 highly relevant articles: the 
first four focused on referral and diagnostic process and the last three on cross-cutting themes (Table 
2). Figure 2 summarises the interrelationship between these PTs, set in the wider context of structural 
and organisational barriers affecting autism diagnostic pathways. Full PTs with CMO configurations 
are provided as Supplementary Document 3.   
Insert: Figure 2. Programme theories for the autism diagnostic pathway  




Table 2: Programme theories and sources 
PTs 1-4: Stage specific programme theories affecting the diagnostic assessment pathway 
PT1 Listening and recognition 
If frontline health and education professionals (e.g. GPs, teachers) are 
confident in recognising the signs and symptoms of autism, are cognisant of 
referral pathways and listen to parents, taking their concerns seriously then 
CYP will be referred to an appropriate service, in a timely manner, reducing 
parental frustration. 
NICE, 2011 (12); Reed and Osborne, 2012 (31); Abbott, et al., 2013 (32); The Scottish 
Government, 2014 (33); Crane, et al., 2016 (6); Rogers, et al., 2016 (34); O'Reilly, et al., 
2017 (35); RCPCH, 2017 (20); Potter, 2017 (36); Unigwe et al., 2017 (37); Crane, et al., 
2018 (38); Dowden, 2018 (39); Rutherford, et al., 2018 (40); Ford, et al., 2019 (41); Hurt, 
et al., 2019 (42). 
PT2 Referral and triaging 
If autism diagnostic services provide clear guidelines for referrers on what 
information is needed and how to refer, and referrers follow these 
guidelines, then time will be saved at the triaging stage and proportionately 
fewer CYP who do not have autism will go through the full process. 
NICE, 2011 (12); Carpenter, 2012 (43); The Scottish Government, 2014 (33); McKenzie, et 
al., 2015 (44); Healthcare Improvement Scotland, 2016 (45); Rutherford, et al., 2016 
(46); Rutherford, et al., 2018 (40); Autistica, 2019 (47); Hurt, et al., 2019 (42); Tollerfield 
and Pearce, 2020 (48). 
PT3 Diagnostic assessment 
If a structured, consistent and multidisciplinary approach to service delivery 
is adopted, making best use of available staff and clinical expertise, then the 
number of assessments per individual may be reduced.  
If a balance of interview, observation and recognised tools are used, 
alongside an assets-based approach, this will ensure a comprehensive and 
family-friendly diagnostic experience. 
If the same Trust manages both community paediatrics and mental health 
services, this potentially allows for a seamless transition, avoids duplicate 
waits and enables families to see all relevant professionals at the same time. 
Carpenter, 2012 (43); NICE, 2014a (49); Karim, et al., 2014 (50); Gray, et al., 2015 (51); 
Crane, et al., 2016 (6); Halpin, 2016 (52); Healthcare Improvement Scotland, 2016 (45); 
McKenzie, et al., 2016 (53); Rogers, et al., 2016 (34); Rutherford, et al., 2016 (46); 
Tryfona, et al., 2016 (54); Galliver, et al., 2017 (13); Jordan, et al., 2017 (55); Juárez, et 
al., 2018 (56); Rutherford, et al., 2018 (40); Ahlers, et al., 2019 (57); Autistica, 2019 (47); 
Ford, et al., 2019 (41); Tollerfield and Pearce, 2020 (48). 




If parents understand the diagnostic process and feel supported this can 
moderate parental expectations. Feedback should take an assets-based 
approach and management plans should be individualised, taking account of 
co-existing conditions. Reports should be timely and in a format that 
everyone finds helpful. 
NICE, 2011 (12); RASDN, 2011 (58); Calzada, et al., 2012 (59); Carpenter, 2012 (43); Reed 
and Osborne, 2012 (31); Abbott, et al., 2013 (32); Karim, et al., 2014 (50); NICE, 2014a 
(49); The Scottish Government, 2014 (33); Halpin, 2016 (52); Healthcare Improvement 
Scotland, 2016 (45); Hennel, et al., 2016 (60); McKenzie, et al., 2016 (53); Reed, et al., 
2016 (61); Rogers, et al., 2016 (34); Crane, et al., 2018 (38); The Scottish Government, 
2018 (62); Autistica, 2019 (47); Hurt, et al., 2019 (42); Tollerfield and Pearce, 2020 (48). 
PTs 5-7: Cross-cutting programme theories affecting the diagnostic pathway 
PT5: Working in partnership with families 
If parents have a single point of contact, are provided explanations 
throughout and included in decision-making then diagnostic pathway may be 
less stressful. 
Calzada, et al., 2012 (59); Abbott, et al., 2013 (32); Gregory, et al., 2013b (63); NICE, 
2014a (49); Rogers, et al., 2016 (34); Healthcare Improvement Scotland, 2016 (45); 
Crane, et al., 2018 (38). 
PT6: Inter-agency working 
If “experts” including people with autism, carers, professionals and specialist 
organisations work in partnership and the knowledge generated is effectively 
embedded into local services, this will build capacity, improve parent/CYP 
satisfaction and support planning of services both locally and nationally. 
NICE, 2011 (12); Calzada, et al., 2012 (59); Gregory, et al., 2013a (64); Gregory, et al., 
2013b (63); Karim, et al., 2014 (50); NICE, 2014a (49); The Scottish Government, 2014 
(33); Gray, et al., 2015 (51); Healthcare Improvement Scotland, 2016 (45); Rogers, et al., 
2016 (34); Galliver, et al., 2017 (13); Hayes, et al., 2018 (65); The Scottish Government, 
2018 (62); Williams et al., 2018 (66); Hurt, et al., 2019 (42); Tollerfield and Pearce, 2020 
(48). 
PT7: Training, service development and evaluation 
If professionals have access to tailored training based on their needs, 
competencies and role, and services engage in service development and 
evaluation, this will increase the local skill set of people who regularly work 
with CYP who may have autism. 
NICE, 2011 (12); Gregory, et al., 2013a (64); Autism ACHIEVE Alliance, 2014 (67); NHS 
Education for Scotland, 2014 (68); The Scottish Government, 2014 (33); Rutherford, et 







PT1: Listening and recognition 
Professionals had to balance early referral with parents’ concerns so that they felt listened to and 
taken seriously (6, 32, 35); parents were often the first to notice atypical patterns of development or 
behaviour in their child (6, 32, 35, 36, 39). Managing parental expectations (42) and developing a co-
operative relationship appeared to help manage this balance but ‘was perceived to be particularly 
problematic because access to services is based on diagnosis, rather than an assessment of the child 
and family’s needs’ (42, p.215). From parents’ perspective, one autism charity website suggested they 
“develop a talent for making a polite nuisance of themselves (more properly known as ‘advocacy’)” to 
traverse barriers to referral (39, p.29). 
Additionally, greater autism awareness and training for frontline professionals, particularly general 
practitioners (GPs) and teachers, alongside training in how, when and who to refer to (6, 12, 33, 35, 
37, 39, 46) was suggested as a strategy to improve early identification.  
 
PT2: Referral and triaging  
Comprehensive information gathering pre-assessment reduced the number of contacts, assessment 
duration and total time taken to reach diagnosis (44). A systematic approach to information gathering 
(12, 46, 48) improved efficiency, but referrers also wanted feedback when referrals were declined (12, 
40, 46).  
Innovative approaches to triaging included: sufficient information gathering pre-assessment to enable 
same-day assessment in the context of tertiary services (47, 69, 70); initial interview with an 
experienced clinician (43); community/neurodevelopmental paediatrician carrying out a General 
Developmental Assessment (GDA) (40, 47, 71); assessment by CAMHS or a community paediatrician 
and SALT, then allocating to an abbreviated (local) or complex (specialist) pathway (40); triage 
meetings across CAMHS and CDS (40). However, whether these strategies constituted triaging or the 
first stage in the diagnostic pathway was arguable.  
 
PT3: Diagnostic assessment 
Good practice in the UK (NICE) (12) recognises the importance of multidisciplinary assessment with 
use of information from parents, educational settings and direct observation/assessment of the child 
used as evidence alongside health professional assessment. However, services had different 
condition-specific remits, catchment areas and commissioning agreements. Where community 




allowed a seamless transition, avoiding duplicated waits and enabling families to see all relevant 
professionals at once (18, 47). 
Few papers clearly delineated the service pathway (18, 40, 42, 47, 48, 50, 51) and within these were 
wide variations, including the balance of standardised assessments, observations and clinical 
judgement. As recommended by NICE (12), most services were multidisciplinary, and many offered a 
single point of access, bridging the autism-ADHD diagnostic divide (18, 47). For example, 
Peterborough’s integrated pathway provided assessments for ADHD and autism (18, 47) and 
combined a single point of access with a comprehensive skill mix, including access to therapies. This 
reduced the number of assessments per individual, saved time and money, and provided a better 
diagnostic experience (47). Another approach was to extend the role of available professions, for 
example, by training SALTs to carry out aspects of the assessment previously carried out by child 
psychiatrists (48). However, disadvantages of multidisciplinary assessment and/or multi-agency 
working included being labour intensive and costly (13); being negatively affected by the dissonance 
between medical and educational paradigms (50); and a ‘perceived power differential’ evidenced by 
the ‘decision-making power of doctors and psychologists over other clinicians’ (52, p.322). 
Rutherford et al. (40) presented a multi-agency diagnostic pathway with an ‘abbreviated’ pathway 
when the signs and symptoms of autism were easily identified and a ‘complex’ pathway for CYP with, 
for example, co-existing conditions needing onward referral to a specialist team. This resulted in fewer 
CYP unnecessarily going through the full process, improving the timeliness of assessment (40). 
An interesting theme within the literature considered the balance of clinical expertise against 
standardised assessments. Less experienced clinicians appeared to prefer using standardised tools, 
while more experienced clinicians expressed confidence in their clinical judgement (43). Some 
clinicians found diagnostic tools helpful, while others described them as ‘very cumbersome and very 
time consuming’ (50, p.118). Rogers et al. (34, p.824) referred to ‘upgrading’, whereby the majority of 
professionals (78 out of 116) erred on the side of a positive diagnosis when faced with uncertainty. 
The main reasons were to facilitate access to funding/support (n=17; 22%); enable individuals to get 
a statement of Special Educational Needs (n = 8; 10%); or differing opinions among colleagues in a 
team (n=32; 41%). 
Finally, there was limited but positive literature around the use of technology. Aims included ‘remote’ 
observational assessments carried out by families during a short telehealth assessment to screen for 
autism in children under 3 years (56); using mobile technology to collect observational data in advance 
of formal assessment (54); educational games to assess risk of autism (54); an automated story (‘A 




Performance Tests (72). Our expert stakeholders also suggested that where the presence of ADHD is 
suspected, the use of Qbtest (72) may enable an objective measurement of attention, concentration, 
impulsivity and distractibility but the evidence is limited. Since carrying out the RRR, Lord (73) has 
provided guidance on adapting autism diagnostic assessment during social distancing, including the 
Autism Diagnostic Observation Schedule (ADOS) (although unvalidated), for remote use, 
demonstrating that the current covid-19 crisis has become a driver for telehealth approaches. 
 
PT4: Diagnostic feedback  
Most parents regarded autism diagnosis as a gateway to services (34) but there was no consensus on 
best practice regarding feedback (51). Parents valued a sensitive approach and positive comments 
about their child and their parenting (32) but found it hard to absorb feedback (32, 60). Practical 
strategies included a structured approach; using consistent and straightforward terminology; 
opportunity to ask questions (including later); and recognising their child’s skills/strengths (12, 32, 45, 
50, 60). Guidelines recommended a needs-based and tailored management plan, co-developed with 
parents (12, p.15, 58).  
Only one paper provided detailed information on the report format (48) and used a digital report-
writing tool and visual profiling tool. Reports were available within a few days, enabling parents to 
review the content, improving partnership working. The visual profiling tool provided a concise visual 
aide for understanding, explaining, and communicating the abilities of each CYP. 
 
PT5: Working in partnership with families  
The diagnostic process was enhanced by integrating ‘expertise from several perspectives… that of the 
individual, their family, and the professionals’ (38, p.3762) and acknowledging parents as co-experts. 
When parents understood the diagnostic process in advance, this improved satisfaction and helped 
moderate expectations (32, p.373). Open and honest dialogue involving parents in decision-making 
(34), helped promote engagement and manage differences of opinion (63). Having a named ‘case 
coordinator’ (12) or ‘keyworker’ (49) helped reduce stress and increase engagement (63). Parents 
offered support following diagnosis were, unsurprisingly, more satisfied than those who were not (38). 
A simple suggestion to improve satisfaction was to tailor links to relevant services and explore the full 
range of services that might prove useful (6). Another approach was to help parents develop strategies 
to manage difficulties, for example, meeting families wherever most convenient to reduce non-





PT6: Inter-agency working  
Integrating the pathways into a single assessment process potentially saved time and cost less (13, 18, 
21) but we found little evidence of how to address macro-level constraints such as chronic 
underinvestment (39). Much appeared to rest on personal relationships at the micro-level (64) and/or 
parents co-ordinating services (42). While joint working was endorsed (59, p.240) suggestions to 
promote it were limited to establishing clear pathways (67); creating opportunities to work in different 
teams, such as split posts or secondments (63); and an Additional Learning Needs Coordinator (a 
teacher at the school) (42). 
 
PT7: Training, service evaluation and development  
Several papers identified the importance of training in improving the quality and efficiency of autism 
diagnostic services (33, 40). It was recommended that training should go beyond those working in 
autism services, include the educational sector (62) and be geared to the needs of managers as well 
as frontline staff (33) through multi-agency training (12). 
Rutherford et al. (40) advocated a training framework with different skill levels, depending on the 
‘nature, extent and likely impact of daily contact with individuals with ASD’ (40, p.1583) and now 
reflected in Health Education England recommendations (74). Other training suggestions included an 
opportunity to observe specialist autism services; buddying with experienced clinicians; regular review 
of training needs and succession planning; and a national forum to share experiences and knowledge 
(46, 67).  
Finally, service evaluation was advocated to check adherence to standards/guidelines (20) and provide 
evidence for commissioners (46); one strategy was a guidelines checklist at the front of each patient 
file (46). Service development suggestions included having one person to champion change; 
generating research within clinical teams; encouraging practitioners to co-create contextually 
sensitive solutions (46); and drawing on the expertise of people with autism, carers and specialist 
organisations (33). Our stakeholders highlighted the importance of good quality national data to 
facilitate a whole system approach, with the current approach appearing somewhat fragmented (75).  
Discussion  
This RRR explored diagnostic pathways that have been adopted across the UK, to determine what 
works best, for whom and in what circumstances. Four PTs related to the clinical pathway, addressing 
ways to improve initial recognition of possible autism, referral and triaging, the diagnostic model and 
post-diagnostic feedback. Whilst there were specific service delivery innovations of interest, such as 




appears to be scope to adapt stages within the process. For example, gathering information about a 
CYP’s strengths/needs at the point of referral may enhance the process, regardless of the specific 
model. The three cross-cutting PTs centred on working in partnership with families; inter-agency 
working; and training, service evaluation and development. Collectively, these PTs evidence different 
approaches that could contribute to a better experience for families, improved efficiency (and 
potentially cost savings) and shorter waiting lists.  
Many of the issues identified in the RRR could be addressed by full adherence to NICE guidelines (12) 
and quality standards (76). However, a gap exists between guidelines and local interpretation, 
exacerbated by demand for assessment outstripping capacity and resourcing constraints. In particular, 
the guidelines indicate the need for a team with the competencies to deliver a broader 
neurodevelopmental and mental health assessment, producing a comprehensive description of a 
chid’s strengths and needs, but some services appeared focused solely on autism diagnosis, partly 
reflecting resourcing constraints (33). A broader neurodevelopmental approach (38) may also 
ameliorate the concerns of those families whose child does not meet criteria for an autism diagnosis 
but has significant needs which may otherwise remain, or feel, unrecognised. This would be 
additionally aided by clinical teams resourcing the development of strengths and needs planning or 
working in consort with other agencies.  
As previously noted, there may also be a trade-off between carrying out comprehensive assessments 
for all CYP with possible autism and ‘providing a more streamlined approach that is tailored to the 
child’s presentation’ (77, p.526) which could reduce diagnostic validity. This mirrors feedback from 
our expert stakeholders – that there may need to be a discussion around the potential to increase 
investment in service delivery to enable high quality and timely approach versus the potential 
challenges associated with accepting lower quality and less timely diagnostic assessment. A similar 
approach delivering tiered assessment according to diagnostic complexity, has been recommended 
by recent Australian guidelines (78).  
Whilst the study findings are based on UK literature that relates to the National Health Service where 
health provision is free at the point of care, and insurance-based health economies are different (77), 
the international literature was largely consistent with our findings. For example, recommendations 
to engage families in service design, and to produce a needs-based holistic assessment and report are 
mirrored internationally (78, 79). The seven PTs are echoed overall, for example in New Zealand 
recommendations (66), whilst international research also supports individual PTs, including improving 
knowledge and skills of referrers (80), improving information gathering to inform appropriateness of 
referral (72), and upskilling the diagnostic workforce (81, 82). These are also echoed in 




Internationally, digitally delivered training programmes such as ECHO (Extension for Community 
Healthcare Outcomes) have been developed to enable upskilling of a wider diagnostic workforce, for 
example community general paediatricians in US and Canada (82), whilst the World Health 
Organisation has developed Caregiver Skills Training Programmes to train parents to support their 
children’s development (84). Similarly, the need for social distancing during the Covid pandemic has 
acted as a driver to adopt digital technologies, although some of these had already been developed 
in response to geographical distancing between centralised specialist services and families living in 
widespread rural communities (45). 
 
Implication for practice and future research 
From the PTs we identified six key areas that would benefit from further exploration. These were 
evaluation of: training and support materials available for non-specialist staff and parents/CYP 
accessing the diagnostic pathway which would increase early recognition that a child may need 
assessment and improve information gathering at the point of referral; training packages to upskill 
those working in autism services and the subsequent impact on workforce shortages; asset-based 
approaches to diagnosis, management and support; barriers and facilitators to comprehensive needs-
led diagnostic assessment; approaches to integrating services dealing with autism; and increased use 
of technology in assessment that has already started in the context of COVID-19 (85).  
Strengths and limitations 
The realist approach was well suited to examining and understanding the complexity of autism 
diagnostic assessment, and the challenges of delivering such services in different contexts. We 
developed systematic and focused search strategies, within the parameters of RRR (22), although not 
as extensive as a full realist review. Expert Stakeholder Engagement enhanced the search strategy, 
enabled an iterative approach to identifying relevant literature and was invaluable when synthesising 
the findings. Most papers had limited information on care pathway processes and contextual factors 
(which in realist terminology refers to any trigger that influences responses or resources), or more 
general sub-analysis by demographic/other characteristics, so PTs could only develop based on what 
was reported; this highlights the need for further empirical work which the next phase of this study 
will provide. Primary and background searches were restricted to UK only, given UK NHS context, but 
secondary searches included papers from countries with somewhat similar healthcare systems (USA, 
Canada, Australia, New Zealand) to help elucidate findings, as recommended by our expert 
stakeholders. However, we acknowledge that we may have missed literature from similar health 





In conclusion, this RRR identified important aspects that may contribute to more efficient, high quality 
and family-friendly service delivery. We will test the PTs and how service design could be further 
enhanced in the subsequent stages of the wider RE-ASCed study.  
AUTHORS’ CONTRIBUTIONS:  
VA & WZ: involved in all stages of the review and writing all drafts of this paper 
PW: substantial contribution to writing protocol for the overall RE-ASCeD project, all stages of the 
review and commenting on all drafts of this paper 
WF & IM: substantial contribution to writing protocol for the overall RE-ASCeD project, all stages of 
the review and commenting on drafts of this paper 
JP: substantial contribution to writing protocol for the overall RE-ASCeD project, some stages of the 
review and commenting on a draft of this paper 
VR: substantial contribution to writing protocol for the overall RE-ASCeD project, some stages of the 
review and commenting on a draft of this paper 
AP: designing the search strategy and commenting on the methodology section of this paper 
ACKNOWLEDGEMENTS: We would like to thank other members of the Realist Evaluation of 
Autism ServiCe Delivery (RE-ASCeD) Consortium for their consultation and support: Amanda Allard, 
Assistant Director, Council for Disabled Children; Prof Heather Gage, University of Surrey; Dr Victoria 
Grahame, Cumbria, Northumberland Tyne and Wear NHS Trust; Dr Lorcan Kenny, Autistica; Dr 
Gráinne Saunders, West Sussex Parent Carer Forum; Peter Williams, University of Surrey; Kat 
Wilmore, PPI partner; and members of our Expert Advisory Group.  
COMPETING INTERESTS STATEMENT: No competing interests. 
FUNDING STATEMENT: This work was supported by NHS England and funds were derived from 
the child and young person mental health transformation funding stream, via the Learning Disability 
and Autism Directorate (direct quote from NHS England letter dated 28/8/2019). There is no grant 
number. 





Data sharing statement: All data relevant to the study are included in the article or 
uploaded as supplementary information 
 
Figures: 
- Figure 1. Search and review flow diagram. 






1. Rodgers H, McCluney J. The Prevalence of Autism (including Asperger Syndrome) in School 
Age Children in Northern Ireland 2021. Belfast, Northern Ireland: Information & Analysis Directorate, 
Department of Health; 2021. 
2. Roman-Urrestarazu A, van Kessel R, Allison C, Matthews FE, Brayne C, Baron-Cohen S. 
Association of race/ethnicity and social disadvantage with autism prevalence in 7 million school 
children in England. JAMA Pediatrics. 2021:e210054-e. 
3. Maenner MJ, Shaw KA, Baio J. Prevalence of autism spectrum disorder among children aged 
8 years—autism and developmental disabilities monitoring network, 11 sites, United States, 2016. 
MMWR Surveillance Summaries. 2020;69(4):1-12. 
4. Brett D, Warnell F, McConachie H, Parr JR. Factors Affecting Age at ASD Diagnosis in UK: No 
Evidence that Diagnosis Age has Decreased Between 2004 and 2014. Journal of Autism & 
Developmental Disorders. 2016;46(6):1974-84. 
5. Wigham S, Male I, Farr W, Reddy V, Parr J. UK childhood autism diagnostic services survey 
2020: Challenges and Innovations. Archives of Disease in Childhood. 2021 (in print). 
6. Crane L, Chester JW, Goddard L, Henry LA, Hill E. Experiences of autism diagnosis: A survey 
of over 1000 parents in the United Kingdom. Autism. 2016;20(2):153-62. 
7. NHS England. NHS Long Term Plan: Learning Disability and Autism. Section 3.31-3.36 2019 
[Available from: https://www.longtermplan.nhs.uk/areas-of-work/learning-disability-autism/. 
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: 
Fifth Edition. Arlington, VA: American Psychiatric Association; 2013. 
9. Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G. Psychiatric disorders in 
children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a 
population-derived sample. Journal of the American Academy of Child & Adolescent Psychiatry. 
2008;47(8):921-9. 
10. Joshi G, Petty C, Wozniak J, Henin A, Fried R, Galdo M, et al. The heavy burden of psychiatric 
comorbidity in youth with autism spectrum disorders: A large comparative study of a psychiatrically 
referred population. Journal of autism and developmental disorders. 2010;40(11):1361-70. 
11. Wistow R, Barnes D. A profile of child and adolescent mental health services in England 
2007/8. 2009 [Available from: https://dro.dur.ac.uk/8221/1/8221.pdf. 
12. National Institute for Health and Care Excellence. Autism spectrum disorder in under 19s: 
recognition, referral and diagnosis  (CG128) London, UK. 2011 [1-45]. Available from: 
https://www.nice.org.uk/guidance/cg128. 
13. Galliver M, Gowling E, Farr W, Gain A, Male I. Cost of assessing a child for possible autism 
spectrum disorder? An observational study of current practice in child development centres in the 
UK. BMJ Paediatrics Open. 2017;1(1). 
14. Male I, Farr W, Gain A, Gowling E, Milton J, Bremner S, et al. How much does it cost to assess 
a child for possible Autism Spectrum Disorder in the UK National Health Service: An Observational 
Study.  European Academy of Childhood Disability,2019. 
15. Vanhaecht K, Sermeus W, Van Zelm R, Panella M. Care Pathways are defined as complex 
interventions. BMC Medicine. 2010;8:31. 
16. Palmer E, Ketteridge C, Parr J, Baird G, Le Couteur A. Autism spectrum disorder diagnostic 
assessments: improvements since publication of the National Autism Plan for Children. Archives of 
Disease in Childhood. 2011;96(5):473-5. 
17. Male I, Reddy V. Should ADHD, ASD & related services be delivered in an integrated way? 
BACCHNEWS. 2018. 
18. Male I, Farr W, Reddy V. Should clinical services for children with possible ADHD, autism or 
related conditions be delivered in an integrated neurodevelopmental pathway? Integrated 




19. Abrahamson V, Zhang W, Wilson P, Farr W, Male I. Realist Evaluation of Autism ServiCe 
Delivery (RE-ASCeD): which diagnostic pathways work best, for whom and in what context? Protocol 
for a rapid realist review. BMJ Open. 2020;10(7):e037846. 
20. RCPCH. Invited reviews the first four years 2017 [Available from: 
https://www.rcpch.ac.uk/sites/default/files/Invited_Reviews_evaluation_report_2016.pdf. 
21. BACCH. A workforce strategy for community paediatrics. London: British Association for 
Community Child Health; 2019 October. 
22. Saul JE, Willis CD, Bitz J, Best A. A time-responsive tool for informing policy making: rapid 
realist review. Implementation Science. 2013;8(1):103. 
23. NIHR Centre for Engagement and Dissemination. UK Standards for Public Involvement 2021 
[Available from: https://sites.google.com/nihr.ac.uk/pi-standards/home. 
24. Wong G, Greenhalgh T, Westhorp G, Buckingham J, Pawson R. RAMESES publication 
standards: realist syntheses. BMC Medicine. 2013;11(1):21. 
25. Williams AC. Autoextraction of twelve permanent teeth in a child with autistic spectrum 
disorder. International Journal of Paediatric Dentistry. 2016;26(2):157-9. 
26. Weetman K, Wong G, Scott E, et al. Improving best practise for patients receiving hospital 
discharge letters: a realist review protocol. BMJ Open. 2017;7(e018353). 
27. Gilmore B, McAuliffe E, Power J, Vallières F. Data analysis and synthesis within a realist 
evaluation: toward more transparent methodological approaches. International Journal of 
Qualitative Methods. 2019;18:1609406919859754. 
28. Pawson R. Digging for nuggets: how ‘bad’research can yield ‘good’evidence. International 
Journal of Social Research Methodology. 2006;9(2):127-42. 
29. Pearson M, Brand SL, Quinn C, Shaw J, Maguire M, Michie S, et al. Using realist review to 
inform intervention development: methodological illustration and conceptual platform for 
collaborative care in offender mental health. Implementation Science. 2015;10(1):134. 
30. Willis C, Saul J, Bitz J, Pompu K, Best A, Jackson B. Improving organizational capacity to 
address health literacy in public health: a rapid realist review. Public Health. 2014;128(6):515-24. 
31. Reed P, Osborne LA. Diagnostic practice and its impacts on parental health and child 
behaviour problems in autism spectrum disorders. Archives of Disease in Childhood. 
2012;97(10):927-31. 
32. Abbott M, Bernard P, Forge J. Communicating a diagnosis of Autism Spectrum Disorder - a 
qualitative study of parents' experiences. Clinical Child Psychology & Psychiatry. 2013;18(3):370-82. 
33. The Scottish Government. Scottish Strategy Mapping Report 2014 [Available from: 
http://www.autismstrategyscotland.org.uk/strategy/key-documents.html. 
34. Rogers CL, Goddard L, Hill EL, Henry LA, Crane L. Experiences of diagnosing autism spectrum 
disorder: A survey of professionals in the United Kingdom. Autism. 2016;20(7):820-31. 
35. O'Reilly M, Lester JN, Muskett T, Karim K. How parents build a case for autism spectrum 
disorder during initial assessments: 'We're fighting a losing battle'. Discourse Stud. 2017;19(1):69-83. 
36. Potter CA. 'I received a leaflet and that is all': Father experiences of a diagnosis of autism. 
British Journal of Learning Disabilities. 2017;45(2):95-105. 
37. Unigwe S, Buckley C, Crane L, Kenny L, Remington A, Pellicano E. GPs' confidence in caring 
for their patients on the autism spectrum: an online self-report study. British Journal of General 
Practice. 2017;67(659):E445-E52. 
38. Crane L, Batty R, Adeyinka H, Goddard L, Henry LA, Hill EL. Autism Diagnosis in the United 
Kingdom: Perspectives of Autistic Adults, Parents and Professionals. Journal of Autism & 
Developmental Disorders. 2018;48(11):3761-72. 
39. Dowden A. Improving the diagnosis of autism spectrum disorder. Prescriber. 
2018;October:28-30. 
40. Rutherford M, Burns M, Gray D, Bremner L, Clegg S, Russell L, et al. Improving efficiency and 
quality of the children’s ASD diagnostic pathway: Lessons learned from practice. Journal of autism 




41. Ford T, Kenchington R, Norman S, Hancock J, Smalley A, Henley W, et al. The agreement 
between the referrer, practitioner and research diagnosis of autistic spectrum conditions among 
children attending child and adolescent mental health services. European Child and Adolescent 
Psychiatry. 2019;28(9):1253-64. 
42. Hurt L, Langley K, North K, Southern A, Copeland L, Gillard J, et al. Understanding and 
improving the care pathway for children with autism. International Journal of Health Care Quality 
Assurance. 2019;32(1):208-23. 
43. Carpenter P. Diagnosis and assessment in autism spectrum disorders. Advances in Mental 
Health & Intellectual Disabilities. 2012;6(3):121-9. 
44. McKenzie K, Forsyth K, O'Hare A, McClure I, Rutherford M, Murray A, et al. Factors 
influencing waiting times for diagnosis of Autism Spectrum Disorder in children and adults. Research 
in Developmental Disabilities. 2015;45-46:300-6. 
45. Healthcare Improvement Scotland. SIGN 145: Assessment, diagnosis and interventions for 
autism spectrum disorders 2016 [1-83]. Available from: https://www.sign.ac.uk/sign-145-
assessment,-diagnosis-and-interventions-for-autism-spectrum-disorders.html. 
46. Rutherford M, McKenzie K, Forsyth K, McCartney D, O’Hare A, McClure I, et al. Why are they 
waiting? Exploring professional perspectives and developing solutions to delayed diagnosis of autism 
spectrum disorder in adults and children. Research in Autism Spectrum Disorders. 2016;31:53-65. 
47. Autistica. Embracing complexity in diagnosis: multi diagnostic pathways for NDCs 2019 
[Available from: https://embracingcomplexity.org.uk/. 
48. Tollerfield I, Pearce H. Use of the Thinking Patterns in Autism Profiling Model within a 
diagnostic assessment service for autism. Good Autism Practice (GAP). 2020 (pre-submission 
version);21(2):99-117. 
49. National Institute for Health and Care Excellence. CG128 Surveillance report - 
recommendation for guidance executive 2014a [1-98]. Available from: 
https://www.nice.org.uk/guidance/cg128/update/CG128/documents/cg128-autism-in-children-and-
young-people-surveillance-review-decision2. 
50. Karim K, Cook L, O'Reilly M. Diagnosing autistic spectrum disorder in the age of austerity. 
Child: Care, Health & Development. 2014;40(1):115-23. 
51. Gray L, Gibbs J, Jolleff N, Williams J, McConachie H, Parr J. Variable implementation of good 
practice recommendations for the assessment and management of UK children with neurodisability. 
Child: care, health and development. 2015;41(6):938-46. 
52. Halpin J. What do nurses think they are doing in pre-school autism assessment? British 
Journal of Nursing. 2016;25(6):319-23. 
53. McKenzie K, Forsyth K, O'Hare A, McClure I, Rutherford M, Murray A, et al. The relationship 
between waiting times and 'adherence' to the Scottish Intercollegiate Guidelines Network 98 
guideline in autism spectrum disorder diagnostic services in Scotland. Autism. 2016;20(4):395-401. 
54. Tryfona C, Oatley G, Calderon A, Thorne S. M-Health Solutions to Support the National 
Health Service in the Diagnosis and Monitoring of Autism Spectrum Disorders in Young Children. In: 
Antona M, Stephanidis C, editors. Universal Access in Human-Computer Interaction: Users and 
Context Diversity, Pt Iii. Lecture Notes in Computer Science. 97392016. p. 249-56. 
55. Jordan E, Farr W, Fager S, Male I. Pirate adventure autism assessment app: a new tool to aid 
clinical assessment of children with possible autistic spectrum disorder. In: Powell W, Rizzo A, 
Sharkey P, Merrick J, editors. Rehabilitation: Innovation and Challenges in the use of Virtual Reality 
Technologies NY, US: Nova Publishers 2017. p. 27-38. 
56. Juárez AP, Weitlauf AS, Nicholson A, Pasternak A, Broderick N, Hine J, et al. Early 
identification of ASD through telemedicine: Potential value for underserved populations. Journal of 
Autism and Developmental Disorders. 2018;48(8):2601-10. 
57. Ahlers K, Gabrielsen TP, Ellzey A, Brady A, Litchford A, Fox J, et al. A pilot project using 
pediatricians as initial diagnosticians in multidisciplinary autism evaluations for young children. 




58. RASDN. Six Steps of Autism Care - for Children and Young People in Northern Ireland 2011 
[Available from: https://www.familysupportni.gov.uk/Content/uploads/userUploads/ASD%20-
%20Six%20Steps%20of%20Autism%20Care%20Pathway%20Report%20-%20PDF%203MB.pdf  
59. Calzada LR, Pistrang N, Mandy WP. High-functioning autism and Asperger's disorder: Utility 
and meaning for families. Journal of Autism and Developmental Disorders. 2012;42(2):230-43. 
60. Hennel S, Coates C, Symeonides C, Gulenc A, Smith L, Price AM, et al. Diagnosing autism: 
Contemporaneous surveys of parent needs and paediatric practice. Journal of Paediatrics and Child 
Health. 2016;52(5):506-11. 
61. Reed P, Picton L, Grainger N, Osborne LA. Impact of Diagnostic Practices on the Self-
Reported Health of Mothers of Recently Diagnosed Children with ASD. International Journal of 
Environmental Research & Public Health [Electronic Resource]. 2016;13(9):07. 
62. The Scottish Government. The Scottish Strategy for Autism - Engagement Analysis 2018 
Edinburgh2018 [Available from: http://www.autismstrategyscotland.org.uk/strategy/key-
documents.html. 
63. Gregory S, Arnold T, Sharman C, Fraser E, Lack N, Froggatt H, et al. The development of a 
Child and Adolescent Mental Health Service for children with disabilities: rationale for the approach, 
method and techniques. Good Autism Practice. 2013b;14(1):74-9. 
64. Gregory S, Arnold T, Sharman C, Fraser E, Lack N, Froggatt H, et al. The development of a 
Child and Adolescent Mental Health Service specifically for children with disabilities: reflections on 
the first four years. Good Autism Practice. 2013a;14(1):68-73. 
65. Hayes J, Ford T, Rafeeque H, Russell G. Clinical practice guidelines for diagnosis of autism 
spectrum disorder in adults and children in the UK: a narrative review. BMC Psychiatry. 2018;18(1):1-
25. 
66. Williams AN, Mold B, Kilbey L, Naganna P. Forty years of referrals and outcomes to a UK 
Child Development Centre (CDC): Has demand plateaued? Child: Care, Health & Development. 
2018;44(3):364-9. 
67. Autism ACHIEVE Alliance. ASD: Waiting for Assessment - Executive Summary 2014 [Available 
from: http://www.autismstrategyscotland.org.uk/strategy/key-documents.html. 
68. NHS Education for Scotland. The NHS Education for Scotland Autism Training Framework - 
Optimising Outcomes - A framework for all staff working with people with Autism Spectrum 
Disorders, their families and carers. Edinburgh2014 [Available from: 
https://www.knowledge.scot.nhs.uk/media/12392691/sct0117216030-
3%20asd%20training%20framework%20cov_final.pdf. 
69. GOSH Foundation Trust. Neurodevelopmental Assessment Clinic (including the Autism 
Assessment Service). London; 2018.  Contract No.: Ref: 2018F0719. 
70. Cumbria Northumberland Tyne and Wear NHS Foundation Trust. Complex 
Neurodevelopmental Disorders Service (CNDS) for Children and Young People 2018 [Available from: 
https://www.cntw.nhs.uk/resource-library/complex-neuro-developmental-service-cnds/. 
71. Male I, Farr W, Gowling E, Gage H, Bremner S, Gain A. How Much Does it Cost the NHS to 
Assess a Child for Possible Autism: A Prospective Study – Paul Polani award lecture.  British Academy 
of Childhood Disability Annual Conference2018. 
72. QbTech. ADHD Tests 2020 [Available from: https://www.qbtech.com/adhd-tests#. 
73. Lord C. Assessments in this time of social distancing 2020 [Available from: 
https://www.youtube.com/watch?v=sOGv8vbJeeo. 
74. Health Education England. Advanced Clinical Practice: Capabilities framework when working 
with people who have a learning disability and/or autism 2020 [Available from: 
https://skillsforhealth.org.uk/info-hub/learning-disability-and-autism-frameworks-2019/. 
75. Allard A, Fellowes A, Gardiner A, Hart S. It takes leaders to break down siloes. Integrating 





76. National Institute for Health and Care Excellence. QS 51 Autism Quality standard 2014b 
[Available from: https://www.nice.org.uk/guidance/qs51. 
77. Penner M, Anagnostou E, Andoni LY, Ungar WJ. Systematic review of clinical guidance 
documents for autism spectrum disorder diagnostic assessment in select regions. Autism. 
2018;22(5):517-27. 
78. Whitehouse A, Evans K, Eapen V, Wray J. A national guideline for the assessment and 
diagnosis of autism spectrum disorders in Australia. 2018 [Available from: 
https://www.autismcrc.com.au/knowledge-centre/resource/national-guideline  
79. van der Meer L, Evans K. The autism diagnostic process in New Zealand: Final Report. 
Brisbane Autism CRC. 2021. 
80. Gordon-Lipkin E, Foster J, Peacock G. Whittling down the wait time: exploring models to 
minimize the delay from initial concern to diagnosis and treatment of autism spectrum disorder. 
Pediatric Clinics. 2016;63(5):851-9. 
81. Swanson AR, Warren ZE, Stone WL, Vehorn AC, Dohrmann E, Humberd Q. The diagnosis of 
autism in community pediatric settings: Does advanced training facilitate practice change? Autism. 
2014;18(5):555-61. 
82. Sohl K, Mazurek MO, Brown R. ECHO autism: Using technology and mentorship to bridge 
gaps, increase access to care, and bring best practice autism care to primary care. Clinical Pediatrics. 
2017;56(6):509-11. 
83. NHSE and NHSI autism program strategy group. Autism diagnosis and support deep dives. 
NHS England and NHS Improvement; 2020. 
84. Salomone E, Pacione L, Shire S, Brown FL, Reichow B, Servili C. Development of the WHO 
caregiver skills training program for developmental disorders or delays. Frontiers in psychiatry. 
2019;10:769. 
85. Reddy V, Brumpton L. Digital-driven service improvement during the COVID-19 pandemic. 
Paediatrics and Child Health. 2021:1-3. 
 
